http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4045041-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41223070214f47228ac783a51ad8dd89
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2020-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a169f0bd3a0d48d1f354ccfab2961bea
publicationDate 2022-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-4045041-A2
titleOfInvention Desloratadine for the treatment and/or prophylaxis of cancers
abstract Disclosed herein is desloratadine for use in the treatment and/or prophylactic treatment of lung cancer, prostate cancer, pancreatic cancer, gastric cancer, kidney cancer, ovarian cancer, colorectal cancer, Hodgins's disease, bladder cancer, liver cancer, and/or nasopharyngeal cancer.
priorityDate 2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3348
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5133
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID613842
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505589
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554006

Total number of triples: 32.